# Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)

> **NCT01745640** · PHASE2 · COMPLETED · sponsor: **University Hospital, Lille** · enrollment: 63 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** POMALIDOMIDE
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01745640
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01745640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01745640, "Pomalidomide and Dexamethasone Effects in Multiple Myeloma Patients With Del 17p or t (4;14)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01745640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*